by Michael Parson | Feb 4, 2016 | CLIA-Waived
Proper (CLIA) Waived Lab Testing & Protocols CLIA- Clinical Laboratory Improvement Amendments is to ensure timeliness, accurate, and reliability in patient testing. This act falls under strict, high quality standards, wherever the tests were performed. This...
by Michael Parson | Jan 28, 2016 | Pharmacogenomics
Since 2007, when the FDA acknowledged that a blood-thinning drug’s effectiveness (or lack of) could be determined by how a person’s unique genetic structure responded to dosage, the medical field has been questioning its trial-by-error methodology....
by Michael Parson | Jan 27, 2016 | MD Heartpro
Research Current research shows that combining multiple markers, as these tests do, will help assess patients’ risks for cardiovascular problems. Recently, most doctors felt that heart attacks were simply a result of fatty deposits that built up, slowly, on...
by Michael Parson | Jan 25, 2016 | Uncategorized
If you think that a routine lipid screening will be enough to accurately predict your heart attack risk level, think again. While it’s true that getting your cholesterol levels checked does a play an important part in your risk assessment, it does not give you...
